80 Biggest Movers From Yesterday
November 17, 5:37 AM
Gainers
BIMI International Medical Inc. (NASDAQ: BIMI) shares surged 55% to close at $1.00 on Tuesday as the company reported a narrower Q3 loss.
Clene Q3 EPS $0.42 Up From $(0.59) YoY, Sales $110.00K Up From $98.00K YoY
November 9, 8:20 AM
Clene (NASDAQ:CLNN) reported quarterly earnings of $0.42 per share. This is a 171.19 percent increase over losses of $(0.59) per share from the same period last year. The company reported $110.00 thousand in sales this
Clene Q3 EPS $0.42 Up From $(0.59) YoY, Sales $110.00K Up From $98.00K YoY
November 9, 8:20 AM
Clene (NASDAQ:CLNN) reported quarterly earnings of $0.42 per share. This is a 171.19 percent increase over losses of $(0.59) per share from the same period last year. The company reported $110.00 thousand in sales this
71 Biggest Movers From Yesterday
November 3, 3:33 AM
Gainers
Avis Budget Group, Inc. (NASDAQ: CAR) shares climbed 108.3% to close at $357.17 on Tuesday after the company reported better-than-expected Q3 adjusted EPS and sales results and added $1 billion to its buyback.
51 Stocks Moving In Tuesday’s Mid-Day Session
November 2, 12:06 PM
Gainers
Avis Budget Group, Inc. (NASDAQ: CAR) surged 83.9% to $315.37 after the company reported better-than-expected Q3 adjusted EPS and sales results and added $1 billion to its buyback.
Clene’s Amyotrophic Lateral Sclerosis Candidate Disappoints In Mid-Stage Study
November 2, 12:01 PM
Clene Inc (NASDAQ:CLNN) has announced topline data from RESCUE-ALS phase 2 trial evaluating CNM-Au8 for early amyotrophic lateral sclerosis (ALS). The…
44 Biggest Movers From Yesterday
October 5, 5:17 AM
Gainers
Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares climbed 101.9% to close at $31.50 on Monday after the company announced its phase 2 study of XEN1101 for the treatment of epilepsy met all primary and secondary endpoints.